Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting. (Q41135362)
Jump to navigation
Jump to search
scientific article published on 10 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting. |
scientific article published on 10 July 2014 |
Statements
Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting (English)
Anieta M Sieuwerts
John W M Martens
Marion E Meijer-van Gelder
Maria B Lyng
Vanja de Weerd
1 reference